Patent details

Basic Information

Publication number:

EP1820516

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP060772290

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Novel albumin-free factor VIII formulations

French Title of Invention:

Nouvelles formulations de facteur VIII sans albumine

German Title of Invention:

Neue albuminfreie Faktor VIII Formulierungen

SPC Number:

Dates

Filing date:

22/02/2000

Grant date:

24/07/2013

EP Publication Date:

24/07/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/08/2007

EP B1 Publication Date:

24/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/02/2014

Expiration date:

22/02/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/02/2000

 

 

Name:

Baxter International Inc.

Address:

One Baxter Parkway, Deerfield, IL 60015, United States (US)

Name:

University of Connecticut

Address:

263 Farmington Avenue, Farmington, CT 06030-6207, United States (US)

Inventor

1

Name:

Pikal Michael

Address:

United States (US)

2

Name:

Jameel Feroz

Address:

United States (US)

3

Name:

Tchessalov Serguei, University of Connecticut

Address:

United States (US)

4

Name:

Bjornson Erik

Address:

United States (US)

5

Name:

Carpenter John

Address:

United States (US)

6

Name:

Kashi Ramesh

Address:

United States (US)

7

Name:

Besman Marc

Address:

United States (US)

Priority

1

Priority Number:

255279

Priority Date:

22/02/1999

Priority Country:

United States (US)

2

Priority Number:

452752

Priority Date:

01/12/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/10;

Filing date	Document type	Number of pages